Jakub Gołąb

Senior Scientific Advisor, Immunotherapy and Co-founder. Prof. Golab heads the Department of Immunology at the Medical University of Warsaw (MUW), where he manages a group of 40 researchers and thus far promoted 14 PhD students. His group is supported by several grants from national and international sources (FP7, Ministry of Science and Higher Education, Foundation for Polish Science, National Science Center, Polish-Swiss Research Program and the National Centre for Research and Development). He is a recipient of many prestigious awards, including the Prime Minister award for academic achievements. His publication record includes ~100 articles in top journals (citation index >4500 and a Hirsh index of 32). Jakub has also been active in privately funded drug development initiatives and was a member of Selvita SA Scientific Advisory Board. His invention on ‘Novel antibody therapies’ US 2011/0091473 A1 has been sold by MUW to Genmab B.V.

Jakub graduated from the Medical University of Warsaw in 1998. He obtained his Ph.D. in 1999 from the Institute of Biostructure Research in Warsaw and had postdoctoral training in Harvard Institutes of Medicine (1999-2000) and University of Texas Southwestern Medical School (2003).